ReP USP - Resultado da busca

Artigo de periodico
Measles, mumps and rubella vaccine 12 months after hematopoietic stem cell transplantation (2023)
Randi, Bruno Azevedo; Fernandes, Eder Gatti; Higashino, Hermes Ryoiti; Lopes, Marta Heloísa ; Rocha, Vanderson Geraldo ; Costa, Sílvia Figueiredo ; Sartori, Ana Marli Christovam
Source: Revista do instituto de medicina tropical de sao paulo. Unidade: FM
Subjects: CÉLULAS-TRONCO, VACINAS VIRAIS, FÁRMACOS IMUNOSSUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RANDI, Bruno Azevedo et al. Measles, mumps and rubella vaccine 12 months after hematopoietic stem cell transplantation. Revista do instituto de medicina tropical de sao paulo, v. 65, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/52956. Acesso em: 03 nov. 2024.
APA
Randi, B. A., Fernandes, E. G., Higashino, H. R., Lopes, M. H., Rocha, V. G., Costa, S. F., & Sartori, A. M. C. (2023). Measles, mumps and rubella vaccine 12 months after hematopoietic stem cell transplantation. Revista do instituto de medicina tropical de sao paulo, 65. doi:10.1590/S1678-9946202365021
NLM
Randi BA, Fernandes EG, Higashino HR, Lopes MH, Rocha VG, Costa SF, Sartori AMC. Measles, mumps and rubella vaccine 12 months after hematopoietic stem cell transplantation [Internet]. Revista do instituto de medicina tropical de sao paulo. 2023 ; 65[citado 2024 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52956
Vancouver
Randi BA, Fernandes EG, Higashino HR, Lopes MH, Rocha VG, Costa SF, Sartori AMC. Measles, mumps and rubella vaccine 12 months after hematopoietic stem cell transplantation [Internet]. Revista do instituto de medicina tropical de sao paulo. 2023 ; 65[citado 2024 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52956
Artigo de periodico
Use of live viral vaccines after HCT: Still a lot to learn (2023)
Sabaini, Paula Moreira da Silva; Machado, Clarisse Martins
Source: Transplant infectious disease. Unidade: FM
Subjects: ANTICORPOS MONOCLONAIS, VACINAS VIRAIS, PREVENÇÃO DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABAINI, Paula Moreira da Silva e MACHADO, Clarisse Martins. Use of live viral vaccines after HCT: Still a lot to learn. Transplant infectious disease, v. 25, n. 2, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53916. Acesso em: 03 nov. 2024.
APA
Sabaini, P. M. da S., & Machado, C. M. (2023). Use of live viral vaccines after HCT: Still a lot to learn. Transplant infectious disease, 25( 2). doi:10.1111/tid.14044
NLM
Sabaini PM da S, Machado CM. Use of live viral vaccines after HCT: Still a lot to learn [Internet]. Transplant infectious disease. 2023 ; 25( 2):[citado 2024 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53916
Vancouver
Sabaini PM da S, Machado CM. Use of live viral vaccines after HCT: Still a lot to learn [Internet]. Transplant infectious disease. 2023 ; 25( 2):[citado 2024 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53916
Artigo de periodico
Safety and immunogenicity of influenza A(H3N2) component vaccine in juvenile systemic lupus erythematosus (2023)
Aikawa, Nadia Emi ; Borba Neto, Eduardo Ferreira ; Balbi, Verena Andrade ; Sallum, Adriana Maluf Elias ; Buscatti, Izabel Mantovani ; Campos, Lúcia Maria Mattei de Arruda; Kozu, Katia Tomie ; Garcia, Cristiana Couto; Capao, Artur Silva Vidal ; Proença, Adriana Coracini Tonacio de ; Leon, Elaine Pires ; Duarte, Alberto José da Silva ; Lopes, Marta Heloísa ; Silva, Clovis Artur Almeida da ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Advances in rheumatology. Unidade: FM
Subjects: LÚPUS ERITEMATOSO SISTÊMICO, VACINAS VIRAIS, INFLUENZA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AIKAWA, Nadia Emi et al. Safety and immunogenicity of influenza A(H3N2) component vaccine in juvenile systemic lupus erythematosus. Advances in rheumatology, v. 63, n. 1, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57309. Acesso em: 03 nov. 2024.
APA
Aikawa, N. E., Borba Neto, E. F., Balbi, V. A., Sallum, A. M. E., Buscatti, I. M., Campos, L. M. M. de A., et al. (2023). Safety and immunogenicity of influenza A(H3N2) component vaccine in juvenile systemic lupus erythematosus. Advances in rheumatology, 63( 1). doi:10.1186/s42358-023-00339-7
NLM
Aikawa NE, Borba Neto EF, Balbi VA, Sallum AME, Buscatti IM, Campos LMM de A, Kozu KT, Garcia CC, Capao ASV, Proença ACT de, Leon EP, Duarte AJ da S, Lopes MH, Silva CAA da, Bonfa ESD de O. Safety and immunogenicity of influenza A(H3N2) component vaccine in juvenile systemic lupus erythematosus [Internet]. Advances in rheumatology. 2023 ; 63( 1):[citado 2024 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57309
Vancouver
Aikawa NE, Borba Neto EF, Balbi VA, Sallum AME, Buscatti IM, Campos LMM de A, Kozu KT, Garcia CC, Capao ASV, Proença ACT de, Leon EP, Duarte AJ da S, Lopes MH, Silva CAA da, Bonfa ESD de O. Safety and immunogenicity of influenza A(H3N2) component vaccine in juvenile systemic lupus erythematosus [Internet]. Advances in rheumatology. 2023 ; 63( 1):[citado 2024 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57309
Artigo de periodico
Intranasal liposomal formulation of spike protein adjuvanted with CpG protects and boosts heterologous immunity of hACE2 transgenic mice to SARS-CoV-2 infection (2023)
Russo, Momtchilo ; Corrêa, Maria Cássia Mendes ; Lins, Bruna Bezerra ; Kersten, Victor; Pernambuco Filho, Paulo Castanho de Almeida ; Martins, Toni Ricardo ; Mendoza, Tânia Regina Tozetto ; Boas, Lucy Santos Vilas ; Gomes, Brisa Moreira; Dati, Lívia Mendonça Munhoz ; Duarte Neto, Amaro Nunes ; Reigado, Gustavo Roncoli ; Frederico, Ana Beatriz T. ; Cunha, Danielle R. de A. de Brito e ; Paula, Anderson Vicente de ; Silva, José Igor Gomes da ; Vasconcelos, Carlos Frederico Alves de ; Alcalde, Felipe Santiago Chambergo ; Dantas, Viviane Abreu Nunes Cerqueira ; Bom, Ana Paula Dinis Ano; Castilho, Leda R. ; Martins, Rodrigo A. P.; Hirata, Mario Hiroyuki ; Mirotti, Luciana
Source: Vaccines. Unidades: ICB, FM, EACH, FCF, BIOTECNOLOGIA
Subjects: IMUNIDADE, CAMUNDONGOS, LIPOSSOMOS, VACINAS VIRAIS, INFECÇÕES POR CORONAVIRUS, COVID-19, ADENOVÍRUS, PROTEÍNAS RECOMBINANTES, GLICOPROTEÍNAS, CAMUNDONGOS, VACINAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUSSO, Momtchilo et al. Intranasal liposomal formulation of spike protein adjuvanted with CpG protects and boosts heterologous immunity of hACE2 transgenic mice to SARS-CoV-2 infection. Vaccines, v. No 2023, n. 11, p. 01-17, 2023Tradução . . Disponível em: http://dx.doi.org/10.3390/vaccines11111732. Acesso em: 03 nov. 2024.
APA
Russo, M., Corrêa, M. C. M., Lins, B. B., Kersten, V., Pernambuco Filho, P. C. de A., Martins, T. R., et al. (2023). Intranasal liposomal formulation of spike protein adjuvanted with CpG protects and boosts heterologous immunity of hACE2 transgenic mice to SARS-CoV-2 infection. Vaccines, No 2023( 11), 01-17. doi:10.3390/vaccines11111732
NLM
Russo M, Corrêa MCM, Lins BB, Kersten V, Pernambuco Filho PC de A, Martins TR, Mendoza TRT, Boas LSV, Gomes BM, Dati LMM, Duarte Neto AN, Reigado GR, Frederico ABT, Cunha DR de A de B e, Paula AV de, Silva JIG da, Vasconcelos CFA de, Alcalde FSC, Dantas VANC, Bom APDA, Castilho LR, Martins RAP, Hirata MH, Mirotti L. Intranasal liposomal formulation of spike protein adjuvanted with CpG protects and boosts heterologous immunity of hACE2 transgenic mice to SARS-CoV-2 infection [Internet]. Vaccines. 2023 ; No 2023( 11): 01-17.[citado 2024 nov. 03 ] Available from: http://dx.doi.org/10.3390/vaccines11111732
Vancouver
Russo M, Corrêa MCM, Lins BB, Kersten V, Pernambuco Filho PC de A, Martins TR, Mendoza TRT, Boas LSV, Gomes BM, Dati LMM, Duarte Neto AN, Reigado GR, Frederico ABT, Cunha DR de A de B e, Paula AV de, Silva JIG da, Vasconcelos CFA de, Alcalde FSC, Dantas VANC, Bom APDA, Castilho LR, Martins RAP, Hirata MH, Mirotti L. Intranasal liposomal formulation of spike protein adjuvanted with CpG protects and boosts heterologous immunity of hACE2 transgenic mice to SARS-CoV-2 infection [Internet]. Vaccines. 2023 ; No 2023( 11): 01-17.[citado 2024 nov. 03 ] Available from: http://dx.doi.org/10.3390/vaccines11111732
Artigo de periodico
Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial (2023)
Medeiros, Roseane P; Terrault, Norah A; Mazo, Daniel F; Oliveira, Claudia Pinto Marques Souza de ; Dodge, Jennifer; Zitelli, Patricia M; Lopes, Marta Heloísa ; Carrilho, Flair Jose ; Pessoa, Mario G
Source: Annals of hepatology. Unidade: FM
Subjects: CIRROSE HEPÁTICA, HEPATITE CRÔNICA, VACINAS VIRAIS, VACINAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEDEIROS, Roseane P et al. Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial. Annals of hepatology, v. 28, n. 2, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/52954. Acesso em: 03 nov. 2024.
APA
Medeiros, R. P., Terrault, N. A., Mazo, D. F., Oliveira, C. P. M. S. de, Dodge, J., Zitelli, P. M., et al. (2023). Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial. Annals of hepatology, 28( 2). doi:10.1016/j.aohep.2022.100891
NLM
Medeiros RP, Terrault NA, Mazo DF, Oliveira CPMS de, Dodge J, Zitelli PM, Lopes MH, Carrilho FJ, Pessoa MG. Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial [Internet]. Annals of hepatology. 2023 ; 28( 2):[citado 2024 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52954
Vancouver
Medeiros RP, Terrault NA, Mazo DF, Oliveira CPMS de, Dodge J, Zitelli PM, Lopes MH, Carrilho FJ, Pessoa MG. Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial [Internet]. Annals of hepatology. 2023 ; 28( 2):[citado 2024 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52954
Artigo de periodico
Humoral and cellular immune responses to CoronaVac up to one year after vaccination (2022)
Costa, Priscilla Ramos; Correia, Carolina Argondizo ; Marmorato, Mariana Prado ; Dias, Juliana Zanatta de Carvalho; Thomazella, Mateus Vailant ; Silva, Amanda Cabral da; Oliveira, Ana Carolina Soares de; Gusmao, Arianne Fagotti; Ferrari, Lilian; Freitas, Angela Carvalho ; Kallas, Esper Georges
Source: Frontiers in immunology. Unidade: FM
Subjects: COVID-19, VACINAS VIRAIS, SISTEMA IMUNE, CITOCINAS, ANTÍGENOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Priscilla Ramos et al. Humoral and cellular immune responses to CoronaVac up to one year after vaccination. Frontiers in immunology, v. 13, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50534. Acesso em: 03 nov. 2024.
APA
Costa, P. R., Correia, C. A., Marmorato, M. P., Dias, J. Z. de C., Thomazella, M. V., Silva, A. C. da, et al. (2022). Humoral and cellular immune responses to CoronaVac up to one year after vaccination. Frontiers in immunology, 13. doi:10.3389/fimmu.2022.1032411
NLM
Costa PR, Correia CA, Marmorato MP, Dias JZ de C, Thomazella MV, Silva AC da, Oliveira ACS de, Gusmao AF, Ferrari L, Freitas AC, Kallas EG. Humoral and cellular immune responses to CoronaVac up to one year after vaccination [Internet]. Frontiers in immunology. 2022 ; 13[citado 2024 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50534
Vancouver
Costa PR, Correia CA, Marmorato MP, Dias JZ de C, Thomazella MV, Silva AC da, Oliveira ACS de, Gusmao AF, Ferrari L, Freitas AC, Kallas EG. Humoral and cellular immune responses to CoronaVac up to one year after vaccination [Internet]. Frontiers in immunology. 2022 ; 13[citado 2024 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50534
Artigo de periodico
Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus (2022)
Yuki, Emily F. N; Borba Neto, Eduardo Ferreira ; Pasoto, Sandra G; Seguro, Luciana P; Lopes, Michelle; Saad, Carla G. S; Silva, Clovis Artur Almeida da ; Kupa, Leonard de Vinci Kanda ; Kallas, Esper Georges ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Arthritis care & research. Unidade: FM
Subjects: ANTICORPOS, VACINAS VIRAIS, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YUKI, Emily F. N et al. Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus. Arthritis care & research, v. 74, n. 4, p. 562-571, 2022Tradução . . Disponível em: https://doi.org/10.1002/acr.24824. Acesso em: 03 nov. 2024.
APA
Yuki, E. F. N., Borba Neto, E. F., Pasoto, S. G., Seguro, L. P., Lopes, M., Saad, C. G. S., et al. (2022). Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus. Arthritis care & research, 74( 4), 562-571. doi:10.1002/acr.24824
NLM
Yuki EFN, Borba Neto EF, Pasoto SG, Seguro LP, Lopes M, Saad CGS, Silva CAA da, Kupa L de VK, Kallas EG, Bonfa ESD de O. Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus [Internet]. Arthritis care & research. 2022 ; 74( 4): 562-571.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1002/acr.24824
Vancouver
Yuki EFN, Borba Neto EF, Pasoto SG, Seguro LP, Lopes M, Saad CGS, Silva CAA da, Kupa L de VK, Kallas EG, Bonfa ESD de O. Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus [Internet]. Arthritis care & research. 2022 ; 74( 4): 562-571.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1002/acr.24824
Artigo de periodico
Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort (2022)
Silveira, Cassia G. T.; Magnani, Diogo M.; Costa, Priscilla R.; Silva, Vivian Helena Iida Avelino da ; Ricciardi, Michael J.; Timenetsky, Maria do Carmo S. T.; Goulart, Raphaella; Correia, Carolina A.; Marmorato, Mariana P.; Ferrari, Lilian; Kalil Filho, Jorge Elias ; Kallas, Esper Georges
Source: Frontiers in immunology. Unidade: FM
Subjects: VACINAS VIRAIS, ADULTOS, INFLUENZA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVEIRA, Cassia G. T. et al. Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort. Frontiers in immunology, v. 13, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.908398. Acesso em: 03 nov. 2024.
APA
Silveira, C. G. T., Magnani, D. M., Costa, P. R., Silva, V. H. I. A. da, Ricciardi, M. J., Timenetsky, M. do C. S. T., et al. (2022). Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort. Frontiers in immunology, 13. doi:10.3389/fimmu.2022.908398
NLM
Silveira CGT, Magnani DM, Costa PR, Silva VHIA da, Ricciardi MJ, Timenetsky M do CST, Goulart R, Correia CA, Marmorato MP, Ferrari L, Kalil Filho JE, Kallas EG. Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort [Internet]. Frontiers in immunology. 2022 ; 13[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fimmu.2022.908398
Vancouver
Silveira CGT, Magnani DM, Costa PR, Silva VHIA da, Ricciardi MJ, Timenetsky M do CST, Goulart R, Correia CA, Marmorato MP, Ferrari L, Kalil Filho JE, Kallas EG. Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort [Internet]. Frontiers in immunology. 2022 ; 13[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fimmu.2022.908398
Artigo de periodico
Impact of polio vaccines (oral polio vaccine-OPV or inactivated polio vaccine-IPV) on rotavirus vaccine-associated intussusception (2022)
Rodrigues, Camila Cristina Martini; Fernandes, Eder Gatti; Santos, Paulo Piva dos; Eguti, Renato Yoshio; Lima, Antonio Carlos Pedroso de ; Tunes, Gisela ; Sartori, Ana Marli Christovam
Source: Human vaccines & immunotherapeutics. Unidades: FM, IME
Subjects: VACINAS VIRAIS, ROTAVIRUS, HOSPITALIZAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Camila Cristina Martini et al. Impact of polio vaccines (oral polio vaccine-OPV or inactivated polio vaccine-IPV) on rotavirus vaccine-associated intussusception. Human vaccines & immunotherapeutics, v. 18, n. 5, 2022Tradução . . Disponível em: https://doi.org/10.1080/21645515.2022.2063594. Acesso em: 03 nov. 2024.
APA
Rodrigues, C. C. M., Fernandes, E. G., Santos, P. P. dos, Eguti, R. Y., Lima, A. C. P. de, Tunes, G., & Sartori, A. M. C. (2022). Impact of polio vaccines (oral polio vaccine-OPV or inactivated polio vaccine-IPV) on rotavirus vaccine-associated intussusception. Human vaccines & immunotherapeutics, 18( 5). doi:10.1080/21645515.2022.2063594
NLM
Rodrigues CCM, Fernandes EG, Santos PP dos, Eguti RY, Lima ACP de, Tunes G, Sartori AMC. Impact of polio vaccines (oral polio vaccine-OPV or inactivated polio vaccine-IPV) on rotavirus vaccine-associated intussusception [Internet]. Human vaccines & immunotherapeutics. 2022 ; 18( 5):[citado 2024 nov. 03 ] Available from: https://doi.org/10.1080/21645515.2022.2063594
Vancouver
Rodrigues CCM, Fernandes EG, Santos PP dos, Eguti RY, Lima ACP de, Tunes G, Sartori AMC. Impact of polio vaccines (oral polio vaccine-OPV or inactivated polio vaccine-IPV) on rotavirus vaccine-associated intussusception [Internet]. Human vaccines & immunotherapeutics. 2022 ; 18( 5):[citado 2024 nov. 03 ] Available from: https://doi.org/10.1080/21645515.2022.2063594
Artigo de periodico
Low frequency of SARS-CoV2 infection in daycare centers during the reopening of school activities in the Southeast's poor area of Brazil (2022)
Soares, Graciela dos Santos; Morais, Lucas Vinicius; Silva, Kevin Cezar Nascimento; Ferreira, Elaine Moura; Shio, Marina Tiemi; Romano, Camila Malta; Conde, Carla Regiani; Sabino, Ester Cerdeira ; Franca, Carolina Nunes; Nali, Luiz Henrique
Source: Revista do instituto de medicina tropical de sao paulo. Unidade: FM
Subjects: VACINAÇÃO, VACINAS VIRAIS, RNA VIRAL, CRECHES, TRANSMISSÃO DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOARES, Graciela dos Santos et al. Low frequency of SARS-CoV2 infection in daycare centers during the reopening of school activities in the Southeast's poor area of Brazil. Revista do instituto de medicina tropical de sao paulo, v. 64, 2022Tradução . . Disponível em: https://doi.org/10.1590/S1678-9946202264046. Acesso em: 03 nov. 2024.
APA
Soares, G. dos S., Morais, L. V., Silva, K. C. N., Ferreira, E. M., Shio, M. T., Romano, C. M., et al. (2022). Low frequency of SARS-CoV2 infection in daycare centers during the reopening of school activities in the Southeast's poor area of Brazil. Revista do instituto de medicina tropical de sao paulo, 64. doi:10.1590/S1678-9946202264046
NLM
Soares G dos S, Morais LV, Silva KCN, Ferreira EM, Shio MT, Romano CM, Conde CR, Sabino EC, Franca CN, Nali LH. Low frequency of SARS-CoV2 infection in daycare centers during the reopening of school activities in the Southeast's poor area of Brazil [Internet]. Revista do instituto de medicina tropical de sao paulo. 2022 ; 64[citado 2024 nov. 03 ] Available from: https://doi.org/10.1590/S1678-9946202264046
Vancouver
Soares G dos S, Morais LV, Silva KCN, Ferreira EM, Shio MT, Romano CM, Conde CR, Sabino EC, Franca CN, Nali LH. Low frequency of SARS-CoV2 infection in daycare centers during the reopening of school activities in the Southeast's poor area of Brazil [Internet]. Revista do instituto de medicina tropical de sao paulo. 2022 ; 64[citado 2024 nov. 03 ] Available from: https://doi.org/10.1590/S1678-9946202264046
Artigo de periodico
Adverse events following immunization of elderly with COVID-19 inactivated virus vaccine (CoronaVac) in Southeastern Brazil: an active surveillance study (2022)
Miyaji, Karina Takesaki; Itto, Lucas Yuji Umesaki; Jacintho, Lucas Cauê ; Sales, Amanda Caroline Ribeiro; Hiratsuka, Marcel; Leonel, Fabio Campos; Higa-taniguchi, Keila Tomoko; Picone, Camila Melo; Lara, Amanda Nazareth ; Rodrigues, Camila Cristina Martini; Lopes, Marta Heloísa ; Sartori, Ana Marli Christovam
Source: Revista do instituto de medicina tropical de sao paulo. Unidade: FM
Subjects: COVID-19, IDOSOS, VULNERABILIDADE, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIYAJI, Karina Takesaki et al. Adverse events following immunization of elderly with COVID-19 inactivated virus vaccine (CoronaVac) in Southeastern Brazil: an active surveillance study. Revista do instituto de medicina tropical de sao paulo, v. 64, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50544. Acesso em: 03 nov. 2024.
APA
Miyaji, K. T., Itto, L. Y. U., Jacintho, L. C., Sales, A. C. R., Hiratsuka, M., Leonel, F. C., et al. (2022). Adverse events following immunization of elderly with COVID-19 inactivated virus vaccine (CoronaVac) in Southeastern Brazil: an active surveillance study. Revista do instituto de medicina tropical de sao paulo, 64. doi:10.1590/S1678-9946202264056
NLM
Miyaji KT, Itto LYU, Jacintho LC, Sales ACR, Hiratsuka M, Leonel FC, Higa-taniguchi KT, Picone CM, Lara AN, Rodrigues CCM, Lopes MH, Sartori AMC. Adverse events following immunization of elderly with COVID-19 inactivated virus vaccine (CoronaVac) in Southeastern Brazil: an active surveillance study [Internet]. Revista do instituto de medicina tropical de sao paulo. 2022 ; 64[citado 2024 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50544
Vancouver
Miyaji KT, Itto LYU, Jacintho LC, Sales ACR, Hiratsuka M, Leonel FC, Higa-taniguchi KT, Picone CM, Lara AN, Rodrigues CCM, Lopes MH, Sartori AMC. Adverse events following immunization of elderly with COVID-19 inactivated virus vaccine (CoronaVac) in Southeastern Brazil: an active surveillance study [Internet]. Revista do instituto de medicina tropical de sao paulo. 2022 ; 64[citado 2024 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50544
Artigo de periodico
Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study (2022)
Netto, Lucas C; Ibrahim, Karim Y; Picone, Camila M; Alves, Ana Paula P. S; Aniceto, Eliane V; Santiago, Mariana R; Parmejani, Patricia S. S; Bonfa, Eloisa Silva Dutra de Oliveira ; Kallas, Esper Georges ; Silva, Vivian Helena Iida Avelino da
Source: Lancet hiv. Unidade: FM
Subjects: HIV, COVID-19, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NETTO, Lucas C et al. Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study. Lancet hiv, v. 9, n. 5, p. E323-E331, 2022Tradução . . Disponível em: https://doi.org/10.1016/S2352-3018(22)00033-9. Acesso em: 03 nov. 2024.
APA
Netto, L. C., Ibrahim, K. Y., Picone, C. M., Alves, A. P. P. S., Aniceto, E. V., Santiago, M. R., et al. (2022). Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study. Lancet hiv, 9( 5), E323-E331. doi:10.1016/S2352-3018(22)00033-9
NLM
Netto LC, Ibrahim KY, Picone CM, Alves APPS, Aniceto EV, Santiago MR, Parmejani PSS, Bonfa ESD de O, Kallas EG, Silva VHIA da. Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study [Internet]. Lancet hiv. 2022 ; 9( 5): E323-E331.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/S2352-3018(22)00033-9
Vancouver
Netto LC, Ibrahim KY, Picone CM, Alves APPS, Aniceto EV, Santiago MR, Parmejani PSS, Bonfa ESD de O, Kallas EG, Silva VHIA da. Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study [Internet]. Lancet hiv. 2022 ; 9( 5): E323-E331.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/S2352-3018(22)00033-9
Artigo de periodico
Intradermal delivery of dendritic cell-targeting chimeric mAbs genetically fused to type 2 Dengue virus nonstructural protein 1 (2020)
Pereira, Lennon Ramos ; Vicentin, Elaine Cristina Matos; Pereira, Sara Araujo ; Maeda, Denicar Lina Nascimento Fabris; Alves, Rubens Prince dos Santos ; Santos, Robert Andreata ; Sousa, Francielle Tramontini Gomes de ; Yamamoto, Marcio Massao ; Amarante, Maria Fernanda Castro ; Favaro, Marianna Teixeira de Pinho ; Romano, Camila Malta ; Sabino, Ester Cerdeira ; Boscardin, Silvia Beatriz ; Ferreira, Luís Carlos de Souza
Source: Vaccines. Unidades: ICB, FM
Subjects: PARASITOLOGIA, MICROBIOLOGIA, VÍRUS DA DENGUE, CÉLULAS DENDRÍTICAS, ANTICORPOS MONOCLONAIS, IMUNOGENÉTICA, IMUNOGENICIDADE DA VACINA, VACINAS VIRAIS, FLAVIVIRUS, VÍRUS DE RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Lennon Ramos et al. Intradermal delivery of dendritic cell-targeting chimeric mAbs genetically fused to type 2 Dengue virus nonstructural protein 1. Vaccines, v. 8, p. 19 , 2020Tradução . . Disponível em: https://doi.org/10.3390/vaccines8040565. Acesso em: 03 nov. 2024.
APA
Pereira, L. R., Vicentin, E. C. M., Pereira, S. A., Maeda, D. L. N. F., Alves, R. P. dos S., Santos, R. A., et al. (2020). Intradermal delivery of dendritic cell-targeting chimeric mAbs genetically fused to type 2 Dengue virus nonstructural protein 1. Vaccines, 8, 19 . doi:10.3390/vaccines8040565
NLM
Pereira LR, Vicentin ECM, Pereira SA, Maeda DLNF, Alves RP dos S, Santos RA, Sousa FTG de, Yamamoto MM, Amarante MFC, Favaro MT de P, Romano CM, Sabino EC, Boscardin SB, Ferreira LC de S. Intradermal delivery of dendritic cell-targeting chimeric mAbs genetically fused to type 2 Dengue virus nonstructural protein 1 [Internet]. Vaccines. 2020 ; 8 19 .[citado 2024 nov. 03 ] Available from: https://doi.org/10.3390/vaccines8040565
Vancouver
Pereira LR, Vicentin ECM, Pereira SA, Maeda DLNF, Alves RP dos S, Santos RA, Sousa FTG de, Yamamoto MM, Amarante MFC, Favaro MT de P, Romano CM, Sabino EC, Boscardin SB, Ferreira LC de S. Intradermal delivery of dendritic cell-targeting chimeric mAbs genetically fused to type 2 Dengue virus nonstructural protein 1 [Internet]. Vaccines. 2020 ; 8 19 .[citado 2024 nov. 03 ] Available from: https://doi.org/10.3390/vaccines8040565
Artigo de periodico
Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report (2019)
Wilder-smith, A; Smith, P. G; Luo, R; Kelly-cirino, C; Curry, D; Larson, H; Durbin, A; Chu, M; Sartori, Ana Marli Christovam ; Luna, Expedito José de Albuquerque
Source: Vaccine. Unidade: FM
Subjects: DENGUE, VACINAS VIRAIS, PROGRAMAS DE VACINAÇÃO, TRIAGEM DE MASSA, CAMPANHAS DE VACINAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILDER-SMITH, A et al. Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report. Vaccine, v. 37, n. 36, p. 5137-5146, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2019.07.016. Acesso em: 03 nov. 2024.
APA
Wilder-smith, A., Smith, P. G., Luo, R., Kelly-cirino, C., Curry, D., Larson, H., et al. (2019). Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report. Vaccine, 37( 36), 5137-5146. doi:10.1016/j.vaccine.2019.07.016
NLM
Wilder-smith A, Smith PG, Luo R, Kelly-cirino C, Curry D, Larson H, Durbin A, Chu M, Sartori AMC, Luna EJ de A. Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report [Internet]. Vaccine. 2019 ; 37( 36): 5137-5146.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.vaccine.2019.07.016
Vancouver
Wilder-smith A, Smith PG, Luo R, Kelly-cirino C, Curry D, Larson H, Durbin A, Chu M, Sartori AMC, Luna EJ de A. Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report [Internet]. Vaccine. 2019 ; 37( 36): 5137-5146.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.vaccine.2019.07.016
Artigo de periodico
Adverse events following Quadrivalent HPV vaccination reported in Sao Paulo State, Brazil, in the first three years after introducing the vaccine for routine immunization (March 2014 to December 2016) (2019)
Mauro, Alexandre Blikstad; Fernandes, Eder Gatti; Miyaji, Karina Takesaki; Arantes, Benedito Antonio; Valente, Maria Gomes; Sato, Helena Keico; Sartori, Ana Marli Christovam
Source: Revista do instituto de medicina tropical de sao paulo. Unidade: FM
Subjects: VACINAS VIRAIS, INFECÇÕES POR PAPILLOMAVIRUS, HPV, VIGILÂNCIA EPIDEMIOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAURO, Alexandre Blikstad et al. Adverse events following Quadrivalent HPV vaccination reported in Sao Paulo State, Brazil, in the first three years after introducing the vaccine for routine immunization (March 2014 to December 2016). Revista do instituto de medicina tropical de sao paulo, v. 61, 2019Tradução . . Disponível em: https://doi.org/10.1590/S1678-9946201961043. Acesso em: 03 nov. 2024.
APA
Mauro, A. B., Fernandes, E. G., Miyaji, K. T., Arantes, B. A., Valente, M. G., Sato, H. K., & Sartori, A. M. C. (2019). Adverse events following Quadrivalent HPV vaccination reported in Sao Paulo State, Brazil, in the first three years after introducing the vaccine for routine immunization (March 2014 to December 2016). Revista do instituto de medicina tropical de sao paulo, 61. doi:10.1590/S1678-9946201961043
NLM
Mauro AB, Fernandes EG, Miyaji KT, Arantes BA, Valente MG, Sato HK, Sartori AMC. Adverse events following Quadrivalent HPV vaccination reported in Sao Paulo State, Brazil, in the first three years after introducing the vaccine for routine immunization (March 2014 to December 2016) [Internet]. Revista do instituto de medicina tropical de sao paulo. 2019 ; 61[citado 2024 nov. 03 ] Available from: https://doi.org/10.1590/S1678-9946201961043
Vancouver
Mauro AB, Fernandes EG, Miyaji KT, Arantes BA, Valente MG, Sato HK, Sartori AMC. Adverse events following Quadrivalent HPV vaccination reported in Sao Paulo State, Brazil, in the first three years after introducing the vaccine for routine immunization (March 2014 to December 2016) [Internet]. Revista do instituto de medicina tropical de sao paulo. 2019 ; 61[citado 2024 nov. 03 ] Available from: https://doi.org/10.1590/S1678-9946201961043
Artigo de periodico
First Detection of DS-1-like G1P[8] Double-gene Reassortant Rotavirus Strains on The American Continent, Brazil, 2013 (2019)
Luchs, Adriana; Costa, Antonio Charlys da; Cilli, Audrey; Komninakis, Shirley Cavalcante Vasconcelos; Carmona, Rita de Cassia Compagnoli; Morillo, Simone Guadagnucci; Sabino, Ester Cerdeira; Timenetsky, Maria do Carmo Sampaio Tavares
Source: Scientific reports. Unidade: FM
Subjects: ROTAVIRUS, VACINAS VIRAIS, GENOMAS, GENES VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUCHS, Adriana et al. First Detection of DS-1-like G1P[8] Double-gene Reassortant Rotavirus Strains on The American Continent, Brazil, 2013. Scientific reports, v. 9, 2019Tradução . . Disponível em: https://doi.org/10.1038/s41598-019-38703-7. Acesso em: 03 nov. 2024.
APA
Luchs, A., Costa, A. C. da, Cilli, A., Komninakis, S. C. V., Carmona, R. de C. C., Morillo, S. G., et al. (2019). First Detection of DS-1-like G1P[8] Double-gene Reassortant Rotavirus Strains on The American Continent, Brazil, 2013. Scientific reports, 9. doi:10.1038/s41598-019-38703-7
NLM
Luchs A, Costa AC da, Cilli A, Komninakis SCV, Carmona R de CC, Morillo SG, Sabino EC, Timenetsky M do CST. First Detection of DS-1-like G1P[8] Double-gene Reassortant Rotavirus Strains on The American Continent, Brazil, 2013 [Internet]. Scientific reports. 2019 ; 9[citado 2024 nov. 03 ] Available from: https://doi.org/10.1038/s41598-019-38703-7
Vancouver
Luchs A, Costa AC da, Cilli A, Komninakis SCV, Carmona R de CC, Morillo SG, Sabino EC, Timenetsky M do CST. First Detection of DS-1-like G1P[8] Double-gene Reassortant Rotavirus Strains on The American Continent, Brazil, 2013 [Internet]. Scientific reports. 2019 ; 9[citado 2024 nov. 03 ] Available from: https://doi.org/10.1038/s41598-019-38703-7
Artigo de periodico
Antigenic competition in CD4(+) T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial (2019)
Kallas, Esper Georges ; Grunenberg, Nicole A; Yu, Chenchen; Manso, Bryce; Pantaleo, Giuseppe; Casapia, Martin; Baden, Lindsey R; Valencia, Javier; Sobieszczyk, Magdalena; Hong Van Tieu
Source: Science translational medicine. Unidade: FM
Subjects: VACINAS VIRAIS, ANTI-HIV, LINFÓCITOS T, IMUNOGENICIDADE DA VACINA, ENSAIO LITERÁRIO, MÉTODO DUPLO-CEGO, ESTUDOS MULTICÊNTRICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KALLAS, Esper Georges et al. Antigenic competition in CD4(+) T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial. Science translational medicine, v. 11, n. 519, 2019Tradução . . Disponível em: https://doi.org/10.1126/scitranslmed.aaw1673. Acesso em: 03 nov. 2024.
APA
Kallas, E. G., Grunenberg, N. A., Yu, C., Manso, B., Pantaleo, G., Casapia, M., et al. (2019). Antigenic competition in CD4(+) T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial. Science translational medicine, 11( 519). doi:10.1126/scitranslmed.aaw1673
NLM
Kallas EG, Grunenberg NA, Yu C, Manso B, Pantaleo G, Casapia M, Baden LR, Valencia J, Sobieszczyk M, Hong Van Tieu. Antigenic competition in CD4(+) T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial [Internet]. Science translational medicine. 2019 ; 11( 519):[citado 2024 nov. 03 ] Available from: https://doi.org/10.1126/scitranslmed.aaw1673
Vancouver
Kallas EG, Grunenberg NA, Yu C, Manso B, Pantaleo G, Casapia M, Baden LR, Valencia J, Sobieszczyk M, Hong Van Tieu. Antigenic competition in CD4(+) T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial [Internet]. Science translational medicine. 2019 ; 11( 519):[citado 2024 nov. 03 ] Available from: https://doi.org/10.1126/scitranslmed.aaw1673
Artigo de periodico
Prospective cohort studies to evaluate the safety and immunogenicity of the 2013, 2014, and 2015 seasonal influenza vaccines produced by Instituto Butantan (2018)
Mondini, Gabriella; Lopes, Marta Heloisa; Sartori, Ana Marli Christovam
Source: Revista do instituto de medicina tropical de sao paulo. Unidade: FM
Subjects: PROMOÇÃO DA SAÚDE, VACINAS VIRAIS, INSTITUTOS DE PESQUISA, INFLUENZA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONDINI, Gabriella e LOPES, Marta Heloisa e SARTORI, Ana Marli Christovam. Prospective cohort studies to evaluate the safety and immunogenicity of the 2013, 2014, and 2015 seasonal influenza vaccines produced by Instituto Butantan. Revista do instituto de medicina tropical de sao paulo, v. 60, 2018Tradução . . Disponível em: https://doi.org/10.1590/S1678-9946201860037. Acesso em: 03 nov. 2024.
APA
Mondini, G., Lopes, M. H., & Sartori, A. M. C. (2018). Prospective cohort studies to evaluate the safety and immunogenicity of the 2013, 2014, and 2015 seasonal influenza vaccines produced by Instituto Butantan. Revista do instituto de medicina tropical de sao paulo, 60. doi:10.1590/S1678-9946201860037
NLM
Mondini G, Lopes MH, Sartori AMC. Prospective cohort studies to evaluate the safety and immunogenicity of the 2013, 2014, and 2015 seasonal influenza vaccines produced by Instituto Butantan [Internet]. Revista do instituto de medicina tropical de sao paulo. 2018 ; 60[citado 2024 nov. 03 ] Available from: https://doi.org/10.1590/S1678-9946201860037
Vancouver
Mondini G, Lopes MH, Sartori AMC. Prospective cohort studies to evaluate the safety and immunogenicity of the 2013, 2014, and 2015 seasonal influenza vaccines produced by Instituto Butantan [Internet]. Revista do instituto de medicina tropical de sao paulo. 2018 ; 60[citado 2024 nov. 03 ] Available from: https://doi.org/10.1590/S1678-9946201860037
Artigo de periodico
Vaccine Recommendations for Solid-Organ Transplant Recipients and Donors (2018)
Stucchi, Raquel S. B.; Lopes, Marta Heloisa; Kumar, Deepali; Manuel, Oriol
Source: Transplantation. Unidade: FM
Subjects: DOAÇÃO ENTRE VIVOS, PROMOÇÃO DA SAÚDE, VACINAS VIRAIS, TRANSPLANTE HETERÓLOGO, AMÉRICA LATINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STUCCHI, Raquel S. B. et al. Vaccine Recommendations for Solid-Organ Transplant Recipients and Donors. Transplantation, v. 102, n. 2, p. S72-S80, 2018Tradução . . Disponível em: https://doi.org/10.1097/TP.0000000000002012. Acesso em: 03 nov. 2024.
APA
Stucchi, R. S. B., Lopes, M. H., Kumar, D., & Manuel, O. (2018). Vaccine Recommendations for Solid-Organ Transplant Recipients and Donors. Transplantation, 102( 2), S72-S80. doi:10.1097/TP.0000000000002012
NLM
Stucchi RSB, Lopes MH, Kumar D, Manuel O. Vaccine Recommendations for Solid-Organ Transplant Recipients and Donors [Internet]. Transplantation. 2018 ; 102( 2): S72-S80.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1097/TP.0000000000002012
Vancouver
Stucchi RSB, Lopes MH, Kumar D, Manuel O. Vaccine Recommendations for Solid-Organ Transplant Recipients and Donors [Internet]. Transplantation. 2018 ; 102( 2): S72-S80.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1097/TP.0000000000002012
Artigo de periodico
Challenges of interpreting epidemiologic surveillance pertussis data with changing diagnostic and immunization practices: the case of the state of Sao Paulo, Brazil (2018)
Fernandes, Eder Gatti; Sartori, Ana Marli Christovam; Soarez, Patricia Coelho de; Novaes, Hillegonda Maria Dutilh
Source: Bmc infectious diseases. Unidade: FM
Subjects: CRIANÇAS, VACINAS VIRAIS, VIGILÂNCIA EPIDEMIOLÓGICA, COQUELUCHE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Eder Gatti et al. Challenges of interpreting epidemiologic surveillance pertussis data with changing diagnostic and immunization practices: the case of the state of Sao Paulo, Brazil. Bmc infectious diseases, v. 18, 2018Tradução . . Disponível em: https://doi.org/10.1186/s12879-018-3004-1. Acesso em: 03 nov. 2024.
APA
Fernandes, E. G., Sartori, A. M. C., Soarez, P. C. de, & Novaes, H. M. D. (2018). Challenges of interpreting epidemiologic surveillance pertussis data with changing diagnostic and immunization practices: the case of the state of Sao Paulo, Brazil. Bmc infectious diseases, 18. doi:10.1186/s12879-018-3004-1
NLM
Fernandes EG, Sartori AMC, Soarez PC de, Novaes HMD. Challenges of interpreting epidemiologic surveillance pertussis data with changing diagnostic and immunization practices: the case of the state of Sao Paulo, Brazil [Internet]. Bmc infectious diseases. 2018 ; 18[citado 2024 nov. 03 ] Available from: https://doi.org/10.1186/s12879-018-3004-1
Vancouver
Fernandes EG, Sartori AMC, Soarez PC de, Novaes HMD. Challenges of interpreting epidemiologic surveillance pertussis data with changing diagnostic and immunization practices: the case of the state of Sao Paulo, Brazil [Internet]. Bmc infectious diseases. 2018 ; 18[citado 2024 nov. 03 ] Available from: https://doi.org/10.1186/s12879-018-3004-1

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation